Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Extended-release oxycodone1件: Oxycodone3件: D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
2Oxycodone1件: Oxycodone3件: D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬7件: 6, 13, 46, 70, 226, 231, 298
3Oxycodone by patient-controlled analgesia (PCA)1件: Oxycodone3件: D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 46
4Oxycodone Depot ”Sandoz”, depot tablets1件: Oxycodone3件: D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 298
5OXYCODONE HYDROCHLORIDE1件: Oxycodone3件: D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬4件: 6, 70, 226, 298
6Oxycodone naloxone prolonged release tablets2件: Naloxone,
Oxycodone
5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
7Oxycodone Orion1件: Oxycodone3件: D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 70
8Oxycodone/Acetaminophen2件: Acetaminophen (Synonym: Apo-oxycodone/acet),
Oxycodone
4件: D00217 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)
5件: OPRD1,
OPRK1,
OPRM1,
PTGS1,
PTGS2 💬
28件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Estrogen signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Sphingolipid signaling pathway, TNF signaling pathway, VEGF signaling pathway, cGMP-PKG signaling pathway 💬1件: 231
9Oxycodone/naloxone prolonged release t3件: Manganese citrate,
Naloxone,
Oxycodone
5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
10Oxycodone/Naloxone Prolonged Release tablets2件: Naloxone,
Oxycodone
5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
11Oxycodone/naloxone prolonged release tablets 10 mg /5 mg3件: Manganese citrate,
Naloxone,
Oxycodone
5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
12Oxycodone/naloxone prolonged release tablets 10/5 mg3件: Manganese citrate,
Naloxone,
Oxycodone
5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
13Oxycodone/naloxone prolonged release tablets 20 mg /10 mg3件: Manganese citrate,
Naloxone,
Oxycodone
5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
14Oxycodone/naloxone prolonged release tablets 20/10 mg3件: Manganese citrate,
Naloxone,
Oxycodone
5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
15Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg3件: Manganese citrate,
Naloxone,
Oxycodone
5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
16Oxycodone/naloxone prolonged release tablets 5/2.5 mg3件: Manganese citrate,
Naloxone,
Oxycodone
5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
17PR Oxycodone1件: Oxycodone3件: D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)
3件: OPRD1,
OPRK1,
OPRM1 💬
5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6